Description
Vortixet (Vortioxetine) 20 mg
Vortixet 20 mg is a brand name product identified as containing vortioxetine, an oral antidepressant used in adults for major depressive disorder. Regulatory product information for vortioxetine describes it as a prescription medicine for depression rather than a general mood enhancer or sleep aid.
Active Ingredient and Medicine Class
The verified active ingredient is vortioxetine. It is a serotonin modulator and stimulator (also described as a multimodal antidepressant). It inhibits the serotonin transporter and also acts on several serotonin receptors.
Established Medical Uses
Vortioxetine is established for the treatment of major depressive disorder in adults. This use is supported by regulatory labeling and clinical review literature.
How It Works
Vortioxetine works by increasing serotonin signaling in the brain through serotonin reuptake inhibition and by modulating multiple serotonin receptor subtypes. This combined action is thought to contribute to its antidepressant effect and may also influence cognitive symptoms associated with depression.
Important Safety Information
Vortioxetine should not be used with monoamine oxidase inhibitors (MAOIs), and it must also be avoided with certain MAOI-related treatments such as linezolid or intravenous methylene blue because of the risk of serotonin syndrome. It is also contraindicated in people with known hypersensitivity to vortioxetine or any tablet component. Strong CYP2D6 inhibitors and other medicines that affect serotonin can be clinically important interaction risks.
Possible Side Effects
Commonly reported adverse effects include nausea, and labeling also notes reactions such as headache and other tolerability issues seen in clinical use. Important serious reactions can include serotonin syndrome, unusual bleeding risk when combined with other drugs that affect hemostasis, and discontinuation symptoms if treatment is stopped abruptly.
Scientific Evidence
Peer-reviewed reviews and meta-analyses support vortioxetine as an effective antidepressant for adults with major depressive disorder. The literature also reports a multimodal serotonin mechanism and suggests potential benefit on cognitive symptoms in some patients, although these findings should be interpreted in the context of clinical trial data rather than as a guarantee of individual benefit.
Medical Information Notice
This summary is for educational purposes only and is based on sources available at the time of review. It does not replace the official patient leaflet, prescribing information, or assessment by a qualified healthcare professional.
Medical Sources
- U.S. FDA / DailyMed: TRINTELLIX (vortioxetine) tablets, for oral use — prescribing information. View source
- Garnock-Jones K. “Vortioxetine: a review of its use in major depressive disorder.” CNS Drugs. 2014. PubMed article
